The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Novo Nordisk's Awiqli, a once-weekly basal insulin icodec, for ...

Image Source: Zacks Investment Research The dip in the stock price was primarily observed after the company faced a major setback in July when the FDA rejected its regulatory filing seeking approval ...